Metformin protects against small intestine damage induced by diabetes and dunning’s prostate cancer: A biochemical and histological study


Here are the Metformin protects against small intestine damage induced by diabetes and dunning’s prostate cancer: A biochemical and histological study journals presenting the latest research across various disciplines. From social sciences to technology, each article is expected to provide valuable insights to our readers.

Metformin and its benefits, what is metformin good for, what does metformin do to your stomach, does metformin help the pancreas, the benefits of metformin.

Metformin protects against small intestine damage induced by diabetes and dunning's prostate cancer: A biochemical and histological study

The oral biguanide metformin is used to treat type 2 diabetic mellitus (T2DM). Anti-cancer effects have been proven by metformin in different hormone-sensitive tumors, including breast, pancreatic, colon, and prostate cancer. Therefore, we investigated whether metformin could defend against small intestine damage in Dunning's prostate cancer. The study divided the six groups of male Copenhagen rats into the following categories: control, diabetic (D), cancer (C), diabetic + cancer (DC), cancer + metformin (CM), and diabetic + cancer + metformin (DCM). After sacrifice, the small intestines were removed to assess biochemical markers and histopathological evaluation. Biochemical evaluations showed that glutathione (reduced) levels and other enzyme activities related antioxidant systems, paraoxonase, sodium potassium ATPase, acetylcholinesterase activities were decreased. In contrast, lipid peroxidation, total oxidant status, reactive oxygen species, interleukin-1β, interleuki n-6, tumor necrosis factor-α, sucrase, maltase, trypsin, myeloperoxidase, xanthine oxidase activities, protein carbonyl contents and sialic acid levels were raised in the damaged groups. Treatment with metformin restored all of this. The histological assessment revealed moderate to severe damage in the small intestine following processes D and C. According to the study's findings, metformin treatment led to a notable decline in histopathological damage in the C and DC. A slight lowering in inflammatory cells and an improvement in the damaged gland integrity in the small intestine were noted with metformin treatment.​ Metformin use protected the small intestinal tissue damage and decreased oxidative stress. © The Author(s), under exclusive licence to Springer Nature B.V. 2024.

Authors : Dagsuyu E.; Koroglu P.; Bulan O.K.; Gul I.B.; Yanardag R.

Source : Springer Science and Business Media B.V.

Article Information

Year 2024
Type Article
DOI 10.1007/s10735-024-10252-y
ISSN 15672379
Volume 55

You can download the article here


If You have any problem, contact us here


Support Us:

Download Now Buy me a coffee Request Paper Here